Where does CardioSolv Ablation Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CardioSolv Ablation Technologies, Inc. ranks #45,467 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CardioSolv Ablation Technologies, Inc. hold?

CardioSolv Ablation Technologies, Inc. holds 5 US utility patents granted between 2019 and 2023, spanning 3 technology areas.

What is CardioSolv Ablation Technologies, Inc.'s Innovation Score?

CardioSolv Ablation Technologies, Inc. has an Innovation Score of 28.0 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CardioSolv Ablation Technologies, Inc. focus on?

CardioSolv Ablation Technologies, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents. Grants appear in 3 CPC subclasses total.

Is CardioSolv Ablation Technologies, Inc.'s patent grant rate increasing or decreasing?

CardioSolv Ablation Technologies, Inc.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for CardioSolv Ablation Technologies, Inc.'s patents?

CardioSolv Ablation Technologies, Inc.'s patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CardioSolv Ablation Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

CardioSolv Ablation Technologies, Inc.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardiosolv ranks #45,467 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#45,467
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.0/100): 18.8
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45467 · US Corporation #45,467 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,467/49,997
PHOTO-FINISH Captek Softgel…
CPC-NARROW A61B · 3 areas
INNOV-THIN 28.0/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Captek Softgel International (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
CardioSolv Ablation · this assignee

28
3D Lighting… · lowest

7

What this shows Cardiosolv's Innovation Score is 28.0/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cardiosolv's grants concentrate

CardioSolv Ablation Technologies, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Cardiosolv sits between Captek Softgel International and CareerBuilder, LLC.

Cardiosolv's three-year grant acceleration

CardioSolv Ablation Technologies, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Captek Softgel In…

5
Carbon Robotics

5
Carbylan Therapeu…

5
Cardinal

5
Cardiocom

5
Cardiora Pty

5
Cardware

5
Careerbuilder

5
Cardiosolv Ablati… ◀

5

What this shows CardioSolv holds 5 patents at rank #45,742, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CardioSolv

By rank, the assignees closest to #45,742 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in CardioSolv's primary technology class.

Cardiosolv's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

CardioSolv Ablation Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	20.0%
2020	1	20.0%
2021	1	20.0%
2022	1	20.0%
2023	1	20.0%

Which technologies does CardioSolv Ablation Technologies, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

G06T - Image Data Processing OR Generation, IN General 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#45,467

of 49,997 tracked assignees

Innovation Score

28.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CardioSolv Ablation Technologies, Inc.'s patent record in context - here's where to go next.

CardioSolv Ablation Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #45,467 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CardioSolv Ablation Technologies, Inc. against Captek Softgel International, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.